Spotlight
Video

Axitinib is an Ideal Choice in Refractory Renal Cell Carcinoma

kidneycancer has 684 videos Subscribe Here

Loading........
Description: Brian I. Rini, M.D., Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Center presents Axitinib is an Ideal Choice in Refractory Renal Cell Carcinoma.
Shared By : kidneycancer
Posted on : 11/07/16
Added : 3 years ago
Category : Kidney Cancer